PADI4, an enzyme that converts arginine residues to citrulline resulting in recognition of the citrullinated proteins by the immune system, is highly expressed in GBM (Sase et al., 2017; Neira et al., 2022). This evidence concerns the gene PADI4 and glioblastoma.